AEMD
HEALTHCAREAethlon Medical Inc
AI Insight
What's Moving AEMD Today?
No stock-specific AI insight has been generated for AEMD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.31$27.40
$1.36
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-10.61
Dividend Yield—
Dividend / Share—
ROE-142.9%
Profit Margin—
Debt / Equity—
Trading
Volume141K
Avg Volume (10D)—
Shares Outstanding2.4M
AEMD News
24 articles- Aethlon Medical advances Hemopurifier study as final trial cohort nears completionYahoo Finance·Jun 17, 2026
- Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Strategic Advances Amid Financial ...Yahoo Finance·Jun 17, 2026
- Aethlon Medical (AEMD) flags going-concern risk while advancing Hemopurifier trialsStock Titan·Jun 11, 2026
- AEMD: Clinical Study Advances to Final Cohort; Preclinical Activities ExpandYahoo Finance·Jun 11, 2026
- Aethlon (AEMD) Q4 2026 Earnings TranscriptMotley Fool·Jun 10, 2026
- Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate UpdateYahoo Finance·Jun 10, 2026
- Earnings Scheduled For June 10, 2026Benzinga·Jun 10, 2026
- AEMD Q4'25 Earnings: EPS estimate is (2.17) USDTradingView·Jun 9, 2026
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026Yahoo Finance·Jun 2, 2026
- Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic PreparednessYahoo Finance·May 21, 2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga·May 8, 2026
- AEMD: Hitting Key Milestones as Company Advances Clinical StudyYahoo Finance·Mar 24, 2026
- Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB ReviewYahoo Finance·Mar 24, 2026
- OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCRYahoo Finance·Mar 18, 2026
- AEMD: Positive Takeaways From CEO ChatYahoo Finance·Mar 18, 2026
- Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale InitiativesYahoo Finance·Mar 13, 2026
- Life Sciences Virtual Investor Forum Presentations Now Available for Online ViewingYahoo Finance·Mar 13, 2026
- Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic OpportunitiesYahoo Finance·Mar 12, 2026
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12thYahoo Finance·Mar 10, 2026
- Aethlon Medical to Present at the Life Sciences Investor Forum on March 12thYahoo Finance·Mar 6, 2026
- Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live streamYahoo Finance·Feb 24, 2026
- Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026Yahoo Finance·Feb 23, 2026
- AEMD: Advancing Oncology Trial; Seeking to Simplify - Potentially Broaden – Device ApplicationYahoo Finance·Feb 18, 2026
- Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ...Yahoo Finance·Feb 16, 2026
All 24 articles loaded
Price Data
Open$1.38
Previous Close$1.36
Day High$1.43
Day Low$1.35
52 Week High$27.40
52 Week Low$1.31
52-Week Range
$1.31$27.40
$1.36
Fundamentals
Market Cap$3M
P/E Ratio—
EPS$-10.61
Dividend Yield—
Dividend / Share—
ROE-142.9%
Profit Margin—
Debt / Equity—
Trading
Volume141K
Avg Volume (10D)—
Shares Outstanding2.4M
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—